Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
357.5(c) 359.65(c) 365.8(c) 363.45(c) 362.25(c) Last
875 393 2 123 098 1 078 630 1 328 859 1 046 526 Volume
-0.31% +0.60% +1.71% -0.64% -0.33% Change
More quotes
Estimated financial data (e)
Sales 2021 62 134 M 67 688 M 67 688 M
Net income 2021 15 273 M 16 638 M 16 638 M
Net cash position 2021 4 368 M 4 759 M 4 759 M
P/E ratio 2021 19,7x
Yield 2021 2,57%
Sales 2022 62 457 M 68 041 M 68 041 M
Net income 2022 15 677 M 17 078 M 17 078 M
Net cash position 2022 9 835 M 10 714 M 10 714 M
P/E ratio 2022 18,8x
Yield 2022 2,67%
Capitalization 314 B 341 B 342 B
EV / Sales 2021 4,98x
EV / Sales 2022 4,87x
Nbr of Employees 101 465
Free-Float 83,5%
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The... 
Sector
Pharmaceuticals
Calendar
12/09Presentation
More about the company
Ratings of Roche Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ROCHE HOLDING AG
12/03PAUL BULCKE : Roche says Nestle Chairman Bulcke to leave its board of directors
RE
12/03Roche to Name New Member to Board of Directors, Re-Elect Chairman
DJ
12/03ROCHE : Änderungen im Verwaltungsrat von Roche
PU
12/03Changes in the Board of Directors
AQ
12/03Roche Holding Ltd Announces Paul Bulcke Will Not to Stand for Re-Election to Its Board ..
CI
12/03REMINDER : Invitation to Roche's virtual analyst event during ESMO IO
PU
12/03Roche develops new research test kits for Omicron variant
RE
12/03Roche Unveils Three Testing Kits to Identify Omicron Variant Mutations
MT
12/03Roche develops new test kits for COVID-19 Omicron variant
RE
12/03Roche has rapidly developed additional testing options to differentiate mutations in th..
AQ
12/03Roche Rapidly Developed Additional Testing Options to Differentiate Mutations in the Om..
CI
12/02Chugai Launches a New Educational Website 'So-Zo LABO' Aiming for a Society that Embrac..
AQ
12/02ROCHE HOLDINGS AG : UBS sticks Neutral
MD
12/01Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluati..
AQ
12/01AlphaValue/Baader Europe Lowers Price Target on Roche, Maintains Add Recommendation
MT
More news
News in other languages on ROCHE HOLDING AG
12/03Paul Bulcke tritt nicht mehr als Roche-Verwaltungsrat an
12/03ROCHE : le conseil d'administration va évoluer
12/03PAUL BULCKE : Paul Bulcke tritt nicht mehr zur Wiederwahl für Verwaltungsrat an
12/03Roche prévoit des changements au sein de son conseil d'administration
12/03ROCHE : la FDA homologue Rituxan pour des traitements oncologiques pédiatriques
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 362,25 CHF
Average target price 388,44 CHF
Spread / Average Target 7,23%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Pascale Schmidt Chief Compliance Officer
AndrÚ S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG17.23%341 364
JOHNSON & JOHNSON1.27%419 583
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113